Immediate treatment for recent hepatitis C infection in people with high-risk behaviors: a systematic review and meta-analysis

Direct-acting antivirals (DAAs) are almost exclusively approved for the treatment of chronic HCV. This poses a significant barrier to the treatment of recently acquired HCV because of the limited access to DAAs. This review seeks to address this issue by synthesizing evidence of the benefits and har...

Descripción completa

Detalles Bibliográficos
Autores principales: Manoharan, Lakshmi, Latham, Ned H., Munari, Stephanie C., Traeger, Michael W., Menon, Vinay, Luhmann, Niklas, Baggaley, Rachel, Macdonald, Virginia, Verster, Annette, Siegfried, Nandi, Matthews, Gail V., Stoové, Mark, Hellard, Margaret E., Doyle, Joseph S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027039/
https://www.ncbi.nlm.nih.gov/pubmed/36930865
http://dx.doi.org/10.1097/HC9.0000000000000082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027039/
https://www.ncbi.nlm.nih.gov/pubmed/36930865
http://dx.doi.org/10.1097/HC9.0000000000000082

Ejemplares similares